Clinical Trial

Cocaine Use Reduction and Health

Study Description

Cocaine Use Reduction and Health

Reduced drug use is a clinically meaningful target for treatment development, but few studies have evaluated the positive impacts produced by this behavioral change, preventing adoption of this endpoint in clinical trials. The proposed research will fill that critical knowledge gap by demonstrating the biopsychosocial benefits of reduced cocaine use. These data will be used to change current accepted cocaine treatment endpoints and accelerate identification of therapies for cocaine use disorder.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Behavioral - Contingency Management

Subjects will receive payments for providing cocaine negative urine samples.

Additional Information

Official Study Title

Cardiovascular, Immune and Psychosocial Benefits of Reduced Cocaine Use

Clinical Trial ID

NCT03224546

ParticipAid ID

Rb4o6a